Sapient Therapeutics Announces Positive Phase 1 Results in Part B of Its Solid Dose Prescription CBD Study
LONDON & MELBOURNE, Australia--(BUSINESS WIRE)--Sapient Therapeutics Ltd (“Sapient Therapeuticsâ€), a pioneering biopharmaceutical company specialising in…